These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37939687)

  • 1. Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19.
    Ruggeri T; De Wit Y; Schärz N; van Mierlo G; Angelillo-Scherrer A; Brodard J; Schefold JC; Hirzel C; Jongerius I; Zeerleder S
    J Innate Immun; 2023; 15(1):850-864. PubMed ID: 37939687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps.
    Bautista-Becerril B; Campi-Caballero R; Sevilla-Fuentes S; Hernández-Regino LM; Hanono A; Flores-Bustamante A; González-Flores J; García-Ávila CA; Aquino-Gálvez A; Castillejos-López M; Juárez-Cisneros A; Camarena A
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34066385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.
    Lim MS; Mcrae S
    Crit Rev Oncol Hematol; 2021 Dec; 168():103529. PubMed ID: 34800652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
    Meroni PL; Croci S; Lonati PA; Pregnolato F; Spaggiari L; Besutti G; Bonacini M; Ferrigno I; Rossi A; Hetland G; Hollan I; Cugno M; Tedesco F; Borghi MO; Salvarani C
    Autoimmun Rev; 2023 Jan; 22(1):103232. PubMed ID: 36414219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.
    Mastellos DC; Pires da Silva BGP; Fonseca BAL; Fonseca NP; Auxiliadora-Martins M; Mastaglio S; Ruggeri A; Sironi M; Radermacher P; Chrysanthopoulou A; Skendros P; Ritis K; Manfra I; Iacobelli S; Huber-Lang M; Nilsson B; Yancopoulou D; Connolly ES; Garlanda C; Ciceri F; Risitano AM; Calado RT; Lambris JD
    Clin Immunol; 2020 Nov; 220():108598. PubMed ID: 32961333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil activation and neutrophil extracellular traps (NETs) in COVID-19 ARDS and immunothrombosis.
    Cesta MC; Zippoli M; Marsiglia C; Gavioli EM; Cremonesi G; Khan A; Mantelli F; Allegretti M; Balk R
    Eur J Immunol; 2023 Jan; 53(1):e2250010. PubMed ID: 36239164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
    Gando S; Wada T
    Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.
    Skendros P; Mitsios A; Chrysanthopoulou A; Mastellos DC; Metallidis S; Rafailidis P; Ntinopoulou M; Sertaridou E; Tsironidou V; Tsigalou C; Tektonidou M; Konstantinidis T; Papagoras C; Mitroulis I; Germanidis G; Lambris JD; Ritis K
    J Clin Invest; 2020 Nov; 130(11):6151-6157. PubMed ID: 32759504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
    Zhu Y; Chen X; Liu X
    Front Immunol; 2022; 13():838011. PubMed ID: 35309344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
    Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
    Front Immunol; 2021; 12():716361. PubMed ID: 34491250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones.
    Ebeyer-Masotta M; Eichhorn T; Weiss R; Semak V; Lauková L; Fischer MB; Weber V
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The central role of neutrophil extracellular traps (NETs) and by-products in COVID-19 related pulmonary thrombosis.
    Li S; Wang H; Shao Q
    Immun Inflamm Dis; 2023 Aug; 11(8):e949. PubMed ID: 37647446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients.
    Staats LAN; Pfeiffer H; Knopf J; Lindemann A; Fürst J; Kremer AE; Hackstein H; Neurath MF; Muñoz LE; Achenbach S; Leppkes M; Herrmann M; Schett G; Steffen U
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.
    Middleton EA; He XY; Denorme F; Campbell RA; Ng D; Salvatore SP; Mostyka M; Baxter-Stoltzfus A; Borczuk AC; Loda M; Cody MJ; Manne BK; Portier I; Harris ES; Petrey AC; Beswick EJ; Caulin AF; Iovino A; Abegglen LM; Weyrich AS; Rondina MT; Egeblad M; Schiffman JD; Yost CC
    Blood; 2020 Sep; 136(10):1169-1179. PubMed ID: 32597954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with COVID-19: in the dark-NETs of neutrophils.
    Ackermann M; Anders HJ; Bilyy R; Bowlin GL; Daniel C; De Lorenzo R; Egeblad M; Henneck T; Hidalgo A; Hoffmann M; Hohberger B; Kanthi Y; Kaplan MJ; Knight JS; Knopf J; Kolaczkowska E; Kubes P; Leppkes M; Mahajan A; Manfredi AA; Maueröder C; Maugeri N; Mitroulis I; Muñoz LE; Narasaraju T; Naschberger E; Neeli I; Ng LG; Radic MZ; Ritis K; Rovere-Querini P; Schapher M; Schauer C; Simon HU; Singh J; Skendros P; Stark K; Stürzl M; van der Vlag J; Vandenabeele P; Vitkov L; von Köckritz-Blickwede M; Yanginlar C; Yousefi S; Zarbock A; Schett G; Herrmann M
    Cell Death Differ; 2021 Nov; 28(11):3125-3139. PubMed ID: 34031543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease.
    Szturmowicz M; Demkow U
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free DNA, Neutrophil extracellular traps (NETs), and Endothelial Injury in Coronavirus Disease 2019- (COVID-19-) Associated Acute Kidney Injury.
    Henry BM; de Oliveira MHS; Cheruiyot I; Benoit J; Rose J; Favaloro EJ; Lippi G; Benoit S; Pode Shakked N
    Mediators Inflamm; 2022; 2022():9339411. PubMed ID: 35497096
    [No Abstract]   [Full Text] [Related]  

  • 19. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.
    Sung PS; Yang SP; Peng YC; Sun CP; Tao MH; Hsieh SL
    J Biomed Sci; 2022 Jul; 29(1):52. PubMed ID: 35820906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19.
    Iliadi V; Konstantinidou I; Aftzoglou K; Iliadis S; Konstantinidis TG; Tsigalou C
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.